Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated VICP+VEN and Transplant for Adult ALL
NCT07059156Phase 3Recruiting
- Sponsor
- Shanxi Bethune Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of venetoclax in acute lymphoblastic leukemia (ALL), sponsored by Shanxi Bethune Hospital. Started Jun 2025; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT07059156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07059156.